Struma Ovarii with Follicular Thyroid Carcinoma

Authors

  • Sumedha Gupta VMMC and Safdarjung Hospital New Delhi
  • Varsha Motwani VMMC & Safdarjung Hospital
  • Archana Mishra VMMC & Safdarjung Hospital
  • Dheer Singh Kalwaniya VMMC & Safdarjung Hospital

DOI:

https://doi.org/10.37506/ne7tp428

Keywords:

Struma ovarii, Follicular thyroid carcinoma, clinical manifestation, treatment

Abstract

Struma ovarii (SO) is a rare ovarian tumor, constituting 1% of all ovarian tumors and 3% of ovarian teratomas, predominantly composed of thyroid tissue. While typically benign, SO can undergo malignant transformation. We report a case of a 41-year-old woman with a six-month history of abdominal distention. Imaging revealed a solid cystic mass in the right adnexa with ascites and elevated CA125 levels. The surgical intervention included a hysterectomy and bilateral salpingo-oophorectomy, with pathology confirming struma ovarii with follicular thyroid carcinoma. Postoperative recovery was uneventful, and all follow-up tests were normal. This case underscores the diagnostic challenge posed by SO due to its resemblance to ovarian cancer and highlights the importance of thorough exploration, pathological examination, and long-term follow-up. Serum thyroglobulin levels can be an effective marker for monitoring tumor recurrence. Our findings contribute to the understanding and management of SO with malignant transformation.

References

Hassan A, Saafan MS, Ansari E. The largest reported papillary thyroid carcinoma arising in struma ovarii and metastasis to opposite ovary: case report and review of literature. Thyroid Res 2018;11:10.

Lara C, Cuenca D, Salame L, Padilla-Longoria R, Mercado M. A hormonally active malignant struma ovarii. Case Rep Oncol Med. 2016;2016:2643470.

Zannoni GF, Gallotta V, Legge F, Tarquini E, Scambia G, Ferrandina G. Pseudo-Meigs’ syndrome associated with malignant struma ovarii: a case report. Gynecol Oncol. 2004;94(1):226–228.

Gonet A, Slusarczyk R, Gasior-Perczak D, et al. Papillary thyroid cancer in a struma ovarii in a 17-year-old nulliparous patient: a case report. Diagnostics (Basel) 2020;10:45.

Zhang X, Axiotis C. Thyroid-type carcinoma of struma ovarii. Arch Pathol Lab Med 2010;134:786–91.

Wang S, He X, Yang H, Chen L. Struma Ovarii Associated with Ascites and Elevated CA125: Two Case Reports and Review of the Literature. Int J Womens Health. 2022 Sep 7;14:1291-1296.

Mostaghel N, Enzevaei A, Zare K, Fallahian M. Struma ovarii associated with Pseudo-Meig’s syndrome and high serum level of CA 125; a case report. J Ovarian Res. 2012;5:10.

Ikeuchi T, Koyama T, Tamai K, et al. CT and MRI features of struma ovarii. Abdom Imaging, 37: 905-910, 2012.

Buttin B, Cohn D, Herzog T. Meigs’ syndrome with an elevated CA 125 from benign Brenner tumors. Obstet Gynecol. 2001;98:980–982.

Marti JL, Clark VE, Harper H, et al. Optimal surgical management of well-differentiated thyroid cancer arising in struma ovarii: a series of 4 patients and a review of 53 reported cases. Thyroid. 2012;22:400–6.

Downloads

Published

2025-07-03